Kawasaki disease is an inflammatory illness that mainly affects the blood vessels. It most often occurs in children under 5 years, and it is usually short term but can have heart complications. Early symptoms of Kawasaki disease include high fever for 5 days or more, red eyes, rash, swollen hands and feet, red cracked lips, and swollen neck glands. Most children recover with prompt treatment using intravenous immune globulin and aspirin, and heart monitoring is important. The risk of death is low with timely care, but coronary artery problems can occur if treatment is delayed.
Overview
Kawasaki diseaseSymptoms
Early symptoms of Kawasaki disease include a fever lasting five days or more, rash, red eyes, cracked lips or “strawberry” tongue, and swollen hands and feet. Many children have swollen neck glands and irritability, with peeling skin when fever improves.
Outlook and prognosis
Most children with Kawasaki disease recover well, especially when treated early with IV immunoglobulin and aspirin in the first 10 days. Heart arteries are the main concern; most never develop lasting problems. Regular follow‑up echocardiograms guide activity and long‑term care.
Causes and risk factors
Kawasaki disease likely stems from an abnormal immune reaction to an infection in a genetically susceptible child, with environmental triggers. Risk rises in children under 5, boys, and those of Asian ancestry, with seasonal clusters and sibling history increasing risk.
Genetic influences
Genetics plays a modest role in Kawasaki disease. Risk is higher in some families and in children of East Asian ancestry, suggesting inherited susceptibility, but no single gene explains it. Most cases likely involve a mix of genetic predisposition and environmental triggers.
Diagnosis
Doctors diagnose Kawasaki disease based on persistent fever and a pattern of clinical features, then support it with blood tests. An echocardiogram checks the heart’s coronary arteries. Diagnosis of Kawasaki disease also involves ruling out infections and other causes.
Treatment and drugs
Kawasaki disease is managed promptly with hospital care to calm inflammation and protect the heart. Treatment often includes intravenous immunoglobulin and aspirin, with careful dosing and monitoring. Follow‑up echocardiograms check coronary arteries, and care teams adjust medicines as recovery progresses.
Symptoms
Many families first notice a high, stubborn fever in a child, along with red eyes, a sore-looking mouth, and a spotty rash. Early on, this might look like a routine virus, but the fever lasts and new signs appear over several days. The early symptoms of Kawasaki disease often include swelling of the hands and feet, a swollen neck gland, and unusual fussiness. Because inflammation can affect the heart, recognizing these changes promptly matters.
A high, persistent fever is common, often 39–40°C (102–104°F). It often lasts 5 days or more despite usual fever reducers. In Kawasaki disease, the fever tends to be continuous rather than on-and-off.
Eyes become red and irritated without thick discharge. Light sensitivity may occur. This eye redness in Kawasaki disease can be striking.
Lips can crack and redden, and the tongue can look bumpy and bright red. The throat may feel sore, and the mouth can be very dry. Eating or drinking may be uncomfortable.
A blotchy or patchy rash can appear on the trunk, limbs, or diaper area. It can change in look and location over days. The rash in Kawasaki disease is not usually itchy.
How people usually first notice Kawasaki disease?
Many families first notice Kawasaki disease when a child under 5 develops a high fever that lasts more than 5 days and doesn’t respond well to usual fever reducers, along with red, cracked lips, a very red “strawberry” tongue, and bloodshot eyes without discharge. Parents often see a widespread rash, swelling or redness of the hands and feet (sometimes with peeling skin a week or two later), and enlarged, tender neck glands, which prompts urgent medical care. Doctors think of Kawasaki when these features cluster together, because quick treatment helps protect the heart; these are the first signs of Kawasaki disease and describe how Kawasaki disease is first noticed.
Types of Kawasaki disease
Kawasaki disease is an acute, inflammatory illness, so clinicians don’t recognize distinct genetic variants the way they do in inherited conditions. Instead, symptoms usually unfold in phases over days to weeks, and the pattern can vary from child to child. People may notice different sets of symptoms depending on their situation. When people ask about types of Kawasaki disease, they’re often referring to how completely the classic signs appear and whether the heart becomes involved.
Complete type
Children have the full set of classic signs over several days. These can include fever, rash, red eyes, red or cracked lips and mouth, swollen hands or feet, and swollen neck glands. Early symptoms of Kawasaki disease often begin with a high fever that lasts at least 5 days.
Incomplete type
Not all classic signs show up, especially in very young infants or older children. Fever may be present with only some features, which can make diagnosis harder. Doctors rely on lab tests and heart ultrasound to help confirm this pattern.
Atypical type
Symptoms include unusual features that aren’t part of the standard checklist. There may be more stomach or liver signs, or changes in the urine or joints. This pattern still needs prompt treatment to protect the heart.
With heart involvement
Some children develop swelling of the heart or changes in the coronary arteries. Signs can be subtle at first, like tiredness or irritability, and show up on heart tests rather than by feel. Follow-up imaging helps track recovery.
Without heart involvement
Many children improve quickly with standard treatment and never develop heart artery changes. Fever and other symptoms fade over days, and energy returns over 1–2 weeks. Ongoing check-ins make sure healing stays on track.
What genetics can tell you about symptoms
Some children with genetic changes in immune signaling genes like ITPKC or CASP3 develop more intense inflammation, leading to higher fevers, red eyes, swollen lips, and rash. Variants in FCGR2A and HLA regions are linked to coronary artery involvement and longer-lasting symptoms.
Causes and risk factors
The exact cause of Kawasaki disease is still unknown. Researchers are still learning how these pieces fit together. It likely involves an immune reaction to an infection in a susceptible child, and cases can cluster in winter or spring. Risk factors for Kawasaki disease include being under 5 years old, being a boy, Asian or Pacific Island ancestry, and a family history. There are no known lifestyle risks, and everyday habits do not seem to change the chance of getting it.
Environmental and biological risk factors
Kawasaki disease is an inflammatory illness in children that can develop when certain body-based sensitivities meet outside exposures. Doctors often group risks into internal (biological) and external (environmental). Knowing these patterns helps explain why cases cluster in certain seasons and ages, and what early symptoms of Kawasaki disease might prompt a checkup. Below are the main environmental and biological factors linked to this condition.
Most cases occur in children between 6 months and 5 years. Risk drops sharply in older children and teens.
Boys are affected slightly more often than girls. This biological difference raises risk but does not determine who will get sick.
In many regions, cases of Kawasaki disease rise in late winter and spring. This seasonal pattern suggests outside exposures that fluctuate during the year.
Colds or other respiratory infections sometimes come shortly before illness starts. The germ itself is not the cause, but it may trigger an oversized immune response. Kawasaki disease is not contagious.
Genetic risk factors
Kawasaki disease appears to involve inherited susceptibility that shapes how a child's immune system reacts. Some risk factors are inherited through our genes. Family history and ancestry patterns point to a polygenic background rather than a single gene. These genetic differences may also influence the timing and intensity of early symptoms of Kawasaki disease and the chance of heart vessel complications.
Family history: Children with a sibling or parent who has had Kawasaki disease carry a higher-than-average risk. Clustering in families points to inherited susceptibility rather than one isolated cause.
East Asian ancestry: Children of Japanese, Korean, or Chinese ancestry have higher rates of Kawasaki disease worldwide. This pattern supports a genetic contribution that travels with families across regions.
Male sex: Boys develop Kawasaki disease more often than girls. This sex-linked pattern likely reflects genetic and hormonal influences on immune pathways.
Immune-regulation genes: Variations in genes that tune immune responses can raise susceptibility to this condition. These differences can act like dimmer switches, making inflammation more intense or longer lasting.
HLA types: Certain tissue-matching gene patterns (HLA) have been associated with risk in some populations. These patterns can change how the immune system recognizes potential triggers.
IVIG response genetics: Some inherited variants are linked with lower response to IVIG (intravenous immunoglobulin) treatment and a higher chance of coronary artery changes. Knowing this can help teams plan closer heart monitoring after treatment.
Coronary risk modifiers: Genetic differences influence who develops coronary artery aneurysms during Kawasaki disease. Variants tied to stronger immune activation are associated with more vessel damage.
Twin studies: Higher concordance in identical twins than fraternal twins points to heritable risk. This supports a genetic component without implying a single causative gene.
Polygenic inheritance: No single gene explains Kawasaki disease. Many small-effect changes likely add up to raise risk across different families.
Lifestyle risk factors
Evidence to date shows no well-established lifestyle risk factors for Kawasaki disease. Diet, exercise, and typical home routines have not been shown to meaningfully change the chance of developing this condition. In other words, lifestyle risk factors for Kawasaki disease remain unproven, though healthy habits still support overall child health.
There are currently no established lifestyle behaviors that increase or decrease Kawasaki disease risk. Most cases occur regardless of a child’s diet, activity level, or routine.
No specific foods, supplements, or dietary patterns have been shown to alter Kawasaki disease risk. Balanced nutrition supports general immune function but has not been proven to prevent this condition.
Activity level does not change the chance of developing Kawasaki disease. Children with both high and low activity levels can be affected.
Some studies suggest breastfeeding may modestly lower risk, but findings are mixed and not definitive. Decisions about infant feeding should consider overall benefits and family preferences.
Risk prevention
Kawasaki disease can’t be reliably prevented, but you can lower the chance of heart complications by spotting symptoms early and acting fast. Learn the early symptoms of Kawasaki disease—days of high fever, red eyes, rash, swollen hands/feet, and cracked lips—and seek urgent care if they appear. Screenings and check-ups are part of prevention too. After treatment, careful follow-up helps protect heart health over time.
Watch for early symptoms of Kawasaki disease such as 5 or more days of high fever, red eyes without pus, rash, swollen palms/soles, and cracked red lips. Quick action lowers the risk of coronary artery problems.
If these symptoms cluster, go to urgent care or the emergency department the same day. Earlier diagnosis means earlier treatment and fewer heart complications.
Intravenous immunoglobulin (IVIG) within the first 10 days of illness sharply lowers heart risks. Ask the care team about timing if symptoms started several days ago.
Keep a simple fever log, noting temperature and timing. Persistent high fever despite usual medicines is a key warning sign in Kawasaki disease.
Transmission
Kawasaki disease is not contagious, so it doesn’t spread through coughing, sneezing, touch, food, or water. The exact cause is unknown; most experts think it’s an immune response to a trigger in a child with genetic susceptibility, but there is no person to person transmission of Kawasaki disease. Cases can appear in seasonal clusters or affect siblings around the same time, which likely reflects shared exposures and inherited risk rather than infection. In practical terms, how Kawasaki disease is transmitted is that it isn’t—one child cannot give it to another.
When to test your genes
Kawasaki disease isn’t typically a genetic disorder, so routine genetic testing isn’t recommended. Consider testing only if a clinician suspects a hereditary vasculitis or immune syndrome mimicking Kawasaki disease, or there’s a strong family history of early aneurysms or unexplained childhood inflammatory illnesses. Discuss with a genetics-informed specialist first.
Diagnosis
If you’re wondering how Kawasaki disease is diagnosed, doctors look at a combination of symptoms and test results. Doctors usually begin with a careful exam and questions about the fever and other symptoms. This approach helps confirm the pattern and guides which tests to order next.
A high fever lasting at least 5 days plus a typical mix of features (red eyes, rash, red cracked lips or “strawberry” tongue, swollen hands/feet, and a swollen neck gland) strongly points to Kawasaki disease. Younger infants may show fewer classic signs, so doctors weigh the whole picture along with lab and heart findings.
The exam focuses on the eyes, mouth, skin, hands and feet, and neck to look for the signature changes. Doctors also check joints, lymph nodes, and overall hydration to assess severity and rule out look-alike illnesses.
Blood tests check for inflammation, changes in white blood cells and platelets, anemia, and liver irritation; urine may show mild inflammation without infection. These results support the diagnosis and help identify “incomplete” Kawasaki disease when not all signs are present.
This painless test looks for swelling or enlargement of the coronary arteries and checks heart muscle function. It is done early and repeated over time to monitor recovery and catch complications promptly.
Stages of Kawasaki disease
Doctors describe Kawasaki disease in three time-based phases that unfold over several weeks. The early symptoms of Kawasaki disease typically appear in the first phase, while heart artery risks tend to peak a little later. Different tests may be suggested to help track inflammation and the heart, including echocardiograms and blood work. Prompt treatment in any phase lowers the chance of coronary complications.
Acute phase
High fever usually lasts 5 days or more with rash, red eyes, red or cracked lips, and swollen hands or feet. In Kawasaki disease, blood tests often show high inflammation and doctors may order an echocardiogram to check the heart. Treatment is typically started in this phase.
Subacute phase
Fever settles but peeling skin on the fingers and toes, irritability, belly or joint pain, and very high platelets can appear. This is when the risk of coronary artery problems is highest, so close heart monitoring continues.
Convalescent phase
Most symptoms fade and energy gradually returns as lab markers normalize over weeks. Follow-up visits and repeat heart scans track recovery, and ongoing care is tailored if any coronary changes were found.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after a child is diagnosed with Kawasaki disease. Most children recover fully with prompt treatment, usually a high dose of immune-modulating medicine and aspirin in the hospital. Early care can make a real difference, because it lowers the risk of coronary artery problems—such as swelling or small bulges in the heart’s blood vessels—that can lead to long-term issues if not caught and managed. Death from Kawasaki disease is rare in high‑resource settings, especially when treatment is started within the first 10 days of fever.
The outlook is not the same for everyone, but most children without heart involvement during the acute illness do well and return to normal activities. When coronary arteries are affected, the long-term plan depends on how large the changes are and whether they heal. Some children’s arteries return to normal over months, while others may need years of cardiology follow‑up, medicines to protect the heart, or rarely, procedures. Understanding the prognosis can guide planning and helps families know what to watch for during play, sports, and school.
Looking at the long-term picture can be helpful. Early symptoms of Kawasaki disease—fever, red eyes, rash—fade with treatment, and energy usually returns over days to weeks. If heart tests were normal in the hospital and at the first follow‑up visit, ongoing risks are typically low, and future heart disease risk appears similar to peers. If aneurysms were present, the care team will tailor activity, vaccines, infection precautions, and blood‑thinning or cholesterol‑lowering medicines to lower the chance of clots or artery narrowing over time. Talk with your doctor about what your personal outlook might look like, including how often to repeat heart imaging and when it’s safe to resume sports.
Long-term effects
Kawasaki disease mostly affects the heart’s blood vessels, so the long-term picture centers on heart health. With prompt treatment, most children recover fully and grow up without limits. Long-term effects vary widely, from none at all to changes in the coronary arteries that may need lifelong follow-up. Children treated soon after the early symptoms of Kawasaki disease often avoid heart complications.
Many children have no lasting problems after treatment. They return to regular play, school, and sports without special limits.
Temporary widening of the heart’s coronary arteries can happen after Kawasaki disease. It usually settles back to normal over weeks to months.
Some develop balloon-like weak spots in coronary arteries after Kawasaki disease. These can raise the chance of clots or narrowing years later. Larger aneurysms carry greater long-term risk.
Scarring can narrow a coronary artery over time. This may limit blood flow and increase the chance of chest pain or heart attack later in life.
How is it to live with Kawasaki disease?
Living with Kawasaki disease is usually a short, intense chapter rather than a lifelong identity; most children face several weeks of fever, rash, irritability, and frequent clinic visits, with fatigue and mood changes that can unsettle family routines. Parents and caregivers often juggle medication schedules (like aspirin) and follow-up heart imaging while watching for signs of coronary artery involvement, which can add real anxiety even after the fever fades. For many, life returns to normal once inflammation settles, but if the heart was affected, activity plans and sports may be adjusted for a time, and cardiology check-ins become part of the calendar. Friends, siblings, and teachers may notice a child who tires more easily at first, so gentle expectations and patience from those around them make recovery smoother.
Treatment and drugs
Kawasaki disease is treated promptly to calm the body’s inflammation and protect the heart. Most children receive a one-time infusion of intravenous immunoglobulin (IVIG) along with high-dose aspirin in the hospital; the aspirin dose is later reduced for a few weeks to lower the risk of blood clots while healing continues. If fever or inflammation persists after the first dose, doctors may repeat IVIG or use other anti-inflammatory medicines such as corticosteroids or, in selected cases, targeted biologic drugs. Treatment plans often combine several approaches, and children have regular heart checkups with echocardiograms to watch for coronary artery changes. Ask your doctor about the best starting point for you, including how long your child should continue low-dose aspirin and what follow-up is needed.
Non-drug treatment
Children with Kawasaki disease often feel wiped out, sore, and uncomfortable, so non-drug care focuses on comfort, hydration, and protecting the heart while medical treatment does its job. Alongside medicines, non-drug therapies can steady day-to-day recovery and lower the chance of problems. Early symptoms of Kawasaki disease—like high fever, red eyes, and cracked lips—can be eased with simple comfort measures at home and in the hospital. Your care team will guide timing for activity, school, and follow-up heart checks.
Regular heart checks help spot strain on the heart and the arteries that feed it. Echocardiograms are used to track healing and guide activity limits. Your team will set a follow-up schedule.
Extra fluids prevent dehydration from fever and fast breathing. Offer frequent sips of water or oral rehydration drinks and small, soft meals. Cool foods can be soothing if the mouth is sore.
Use lukewarm sponge baths, light clothing, and a comfortably cool room to ease fevers. Avoid cold baths or ice packs, which can cause shivering and discomfort. Resting in a quiet, dim space can help.
Gentle moisturizers and petroleum jelly can calm peeling skin and cracked lips. Mild, fragrance-free cleansers reduce irritation while the rash heals. Soft toothbrushes and cool liquids may make mouth care easier.
Your genes may have an impact on how drugs work for you
Most people with Kawasaki disease receive the same core treatments, but genes that influence how the immune system reacts can affect how well intravenous immunoglobulin (IVIG) works and the risk of resistance. Genetic differences may also guide steroid use and help anticipate coronary complications.
Pharmacological treatments
Early treatment helps calm the intense inflammation and protect the heart in Kawasaki disease. Care teams aim to start therapy within 10 days of early symptoms of Kawasaki disease, and sooner if possible. First-line medications are those doctors usually try first, based on strong evidence and safety, with other options added if fever or inflammation persist. Most medicines are given in hospital at first, then some continue at home.
Intravenous immunoglobulin (IVIG) is the main early treatment and is given as a single hospital infusion to lower inflammation and protect the coronary arteries. It works best when started within the first 10 days of illness.
High-dose aspirin is used during the fever phase, then a lower daily dose continues for several weeks to prevent blood clots. Your child will be monitored for stomach upset or bleeding, and vaccines or infections like flu or chickenpox may affect timing.
Steroids such as methylprednisolone or prednisone may be added if there is high risk for heart complications or if IVIG does not fully work. They reduce inflammation and require monitoring for blood pressure, blood sugar, and mood changes.
If fever continues after IVIG, a one-time infusion of infliximab may be used to quiet inflammation. It targets a specific immune signal (TNF) and can increase infection risk, so screening and follow-up are important.
Genetic influences
Kawasaki disease appears to have a genetic component, as it’s seen more often in some families and is more common in children of East Asian ancestry, no matter where they live. Family history is one of the strongest clues to a genetic influence. Rather than a single “Kawasaki gene,” several small differences in immune-related genes seem to raise susceptibility, and an infection or other environmental trigger may set off the inflammation that leads to symptoms. These gene differences may also help explain why some children develop coronary artery involvement or don’t respond as well to the first treatment. There is no routine genetic test that can predict who will develop Kawasaki disease, and having a genetic tendency does not mean a child will get it. Genes don’t change the early symptoms of Kawasaki disease, but they may influence how severe the episode is and the chance of complications.
Is Kawasaki disease genetic?
Genetics plays a modest role in Kawasaki disease. Risk is higher in some families and in children of East Asian ancestry, suggesting inherited susceptibility, but no single gene explains it. Most cases likely involve a mix of genetic predisposition and environmental triggers.
Pharmacogenetics—how genetics influence drug effects
Treatment for Kawasaki disease usually starts quickly with intravenous immunoglobulin (IVIG) and aspirin, yet not every child responds the same way. Research suggests that inherited differences in immune system genes may influence how well IVIG calms the inflammation, with some children more likely to have persistent fever after the first dose. Pharmacogenetics is the study of how genes affect drug response — in Kawasaki disease, studies are promising but not yet strong enough to guide day-to-day treatment for most families. Because of this, doctors still rely on clinical signs and how a child is doing after the first infusion, sometimes adding a second IVIG dose, steroids, or a targeted medicine like infliximab if needed. Genes are just one piece of the puzzle—age, timing of therapy, and illness severity also matter. Looking ahead, genetics may help identify children at higher risk of IVIG resistance in Kawasaki disease, but routine genetic testing isn’t currently recommended.
Interactions with other conditions
Respiratory or stomach viruses often come right before Kawasaki disease, and early symptoms of Kawasaki disease can look a lot like common infections such as strep throat, adenovirus, or measles-like rashes, which can make the picture confusing when they occur together. COVID-19 brought attention to a related condition in children called MIS-C; it can mimic Kawasaki disease, and when a recent SARS‑CoV‑2 infection is known, doctors weigh both possibilities because treatments and follow-up can differ. Certain diseases may “overlap,” meaning they share signs like fever, red eyes, and rash, so teams often run tests to rule out illnesses like toxic shock or scarlet fever when the diagnosis isn’t clear. If a child already has a heart condition, the heart inflammation in Kawasaki disease can strain the heart more, and later in life, coronary artery changes from Kawasaki disease can compound other cardiovascular risks like high blood pressure or high cholesterol. When low‑dose aspirin is prescribed after Kawasaki disease, catching flu or chickenpox raises concern for Reye’s syndrome, so prompt medical advice and staying up to date with vaccines—timed around IVIG treatment—matters. Talk with your doctor about how your conditions may influence each other, especially during infections or if heart, rheumatologic, or blood vessel problems are also present.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described clusters of children with sudden high fever, rash, bloodshot eyes, and swollen lips and hands, often during certain seasons. Families remember a toddler who wouldn’t be consoled, lips cracked and bright red, palms peeling days later. These stories sounded like infections or allergies, yet didn’t fit cleanly. From early theories to modern research, the story of Kawasaki disease has moved from puzzling case notes to a clearly defined childhood condition recognized worldwide.
First described in the medical literature as a “mucocutaneous lymph node syndrome” in 1967 by Dr. Tomisaku Kawasaki in Japan, the condition was initially pieced together from patterns he noticed in otherwise healthy young children. Over time, descriptions became more specific: five or more days of fever, a particular mix of rash, eye redness, mouth changes, and swollen lymph nodes. In the 1970s and 1980s, doctors realized that some children also developed inflammation of the coronary arteries, which carry blood to the heart. That discovery shifted the condition from a curious rash-and-fever illness to a time‑sensitive pediatric diagnosis.
Awareness spread quickly across Asia, then to North America and Europe, as pediatricians recognized the same cluster of signs. Once considered rare, now recognized as one of the most common causes of acquired heart disease in children in high‑income countries, Kawasaki disease showed clear patterns: most cases in children under 5, more boys than girls, and seasonal peaks suggesting an environmental trigger. In recent decades, knowledge has built on a long tradition of observation. Public health records in Japan, the United States, and Europe documented periodic surges, while family histories hinted that genetics might influence susceptibility.
Advances in genetics and immunology then deepened the picture. Researchers found gene variants that may tilt the immune system toward an overly strong response in some children, while studies of air currents and microbial exposure explored why outbreaks cluster in time and place. Not every early description was complete, yet together they built the foundation of today’s knowledge. Treatments evolved as well. In the 1980s, giving intravenous immunoglobulin (IVIG) within the first 10 days of illness was shown to sharply reduce the risk of coronary artery problems, changing long‑term outcomes for many living with Kawasaki disease.
Today, history guides practice. Early symptoms of Kawasaki disease are taught in pediatric training so that children are treated promptly, and long‑term follow‑up focuses on heart health when needed. The condition’s past—careful bedside observation, recognition of heart involvement, and the development of timely treatment—continues to shape how clinicians around the world diagnose and manage Kawasaki disease.